Prognostic value of preablative stimulated thyroglobulin and its decline after <sup>131</sup> I therapy in differentiated thyroid cancer
Lower pre-<sup>131</sup>I sTg levels and/or a greater rate of sTg decline after the first <sup>131</sup>I treatment are associated with more favorable clinical outcomes. The proposed nomogram may assist clinicians in optimizing treatment decisions and stratifying follow-up strategies for patients with DTC.
Authors
- Yong Chol Han (ORCID: https://orcid.org/0000-0003-0990-9184)
- Xiaotian Xia (ORCID: https://orcid.org/0000-0002-3917-4361)
- Xiaojing Ren (ORCID: https://orcid.org/0000-0002-0789-8015)
- Zairong Gao
- Yajing Zhang (ORCID: https://orcid.org/0000-0002-0423-4870)
- Yunfei Hou
- Jie Tan (ORCID: https://orcid.org/0000-0001-7284-9298)
- Ruolin Wu
- Jingjing Wang (ORCID: https://orcid.org/0000-0002-8760-8822)
Institutions
- Union Hospital (HK)
- Ministry of Education of the People's Republic of China (CN)
- Ministry of Education (CL)
- State Key Laboratory of Information Engineering in Surveying Mapping and Remote Sensing (CN)
- Henan Provincial People's Hospital (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1080/07853890.2025.2573150
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00